0001209191-23-056425.txt : 20231122 0001209191-23-056425.hdr.sgml : 20231122 20231122134757 ACCESSION NUMBER: 0001209191-23-056425 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231120 FILED AS OF DATE: 20231122 DATE AS OF CHANGE: 20231122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gaiero David G CENTRAL INDEX KEY: 0001799784 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40499 FILM NUMBER: 231432552 MAIL ADDRESS: STREET 1: 733 CONCORD AVENUE STREET 2: C/O WAVE LIFE SCIENCES USA, INC. CITY: CAMBRIDGE STATE: MA ZIP: 02138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc. CENTRAL INDEX KEY: 0001662244 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455429901 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: BUILDING B, SUITE 450 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 857-285-4140 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: BUILDING B, SUITE 450 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-20 0 0001662244 Cyteir Therapeutics, Inc. CYT 0001799784 Gaiero David G C/O CYTEIR THERAPEUTICS, INC. 99 HAYDEN AVE, BUILDING B, SUITE 450 LEXINGTON MA 02421 0 1 0 0 Chief Financial Officer 0 Common Stock 2023-11-20 4 M 0 52584 1.68 A 66684 D Common Stock 2023-11-20 4 M 0 21356 1.69 A 88040 D Stock Option (Right to Buy) 1.68 2023-11-20 4 M 0 52584 0.00 D 2030-12-10 Common Stock 52584 21055 D Stock Option (Right to Buy) 1.69 2023-11-20 4 M 0 21356 0.00 D 2033-02-03 Common Stock 21356 92544 D Includes 5,000 shares of the Company's common stock pursuant to the Cyteir Therapeutics, Inc. Employee Stock Purchase Program ("ESPP"). In accordance with the ESPP, these shares were purchased based on 85% of the closing stock price on January 17, 2023. The option vested as to 25% of the underlying shares of common stock on December 7, 2021, the first anniversary of the vesting commencement date, and vests as to 1/48th of the underlying shares thereafter on each subsequent monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. The option vests as to 1/48th of the underlying shares thereafter on each subsequent monthly anniversary of the vesting commencement date until the option is fully vested, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. /s/ David Gaiero 2023-11-22